| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 728221 | 5,5-Dimethyl-3-[2-(2,3,5,6-tetrachloro-pyridin-4-ylsulfanyl) -vinyl]-cyclohex-2-enone | 0.000880521445136051 | 0.33407199 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.000880521445136057 | 0.79209615 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.000931492155975089 | 0.40916493 |
| NSC 673652 | 2-Ethylaminoestradiol | 0.000931492155975089 | 0.060241438 |
| NSC 287459 | Cytarabine AY | 0.00109467026514912 | 0.81776267 |
| NSC 734294 | Indenoisoquinoline derivative | 0.00119931827492062 | 0.49240107 |
| NSC 740276 | 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide | 0.00119931827492062 | 0.5869118 |
| NSC 628906 | 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Trifluoroacetate. | 0.00138752552318951 | 0.090646155 |
| NSC 669382 | Null | 0.00138752552318951 | 0.070958876 |
| NSC 375162 | Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide | 0.00180888338647612 | 0.36058995 |